Skip to Main Content

Paper Details

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.
Pharmacoepidemiol Drug Saf
30
2022
COVID, COVID-19, CVST, DVT, PE, SVT, TTS, Thrombosis with thrombocytopenia syndrome, cerebral venous sinus thrombosis, deep vein thrombosis, ischemic stroke, men, myocardial infarction, patient, people, person, persons, pulmonary embolism, splanchnic vein thrombosis, thrombocytopenia, thrombosis, women
Author NameAffiliation
Edward BurnFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Edward BurnUniversity of Oxford
Edward BurnFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Edward BurnUniversity of Oxford
Talita Duarte-SallesFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Talita Duarte-SallesFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Mar??a Arag??nFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Mar??a Arag??nFundacio Institut Universitari per a la recerca a l'Atencio Primaria de Salut Jordi Gol i Gurina (IDIAPJGol)
Antonella DelmestriUniversity of Oxford
Peter R RijnbeekErasmus University Medical Center
Peter R RijnbeekErasmus University Medical Center
  • 1 - 11

Datasets

Release 1.2